Revenue | ₹439.27Cr |
Net Profits | ₹140.39Cr |
Net Profit Margins | 31.96% |
Concord Biotech Ltd’s revenue jumped 33.2% since last year same period to ₹439.27Cr in the Q4 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 68.44% jump in its revenue since last 3-months.
Concord Biotech Ltd’s net profit jumped 47.75% since last year same period to ₹140.39Cr in the Q4 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 84.92% jump in its net profits since last 3-months.
Concord Biotech Ltd’s net profit margin jumped 10.92% since last year same period to 31.96% in the Q4 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated 9.78% jumped in its net profit margins since last 3-months.
The revenue for Concord Biotech Ltd in the Q4 results 2024 was ₹439.27Cr.
The net profit for Concord Biotech Ltd in the Q4 results 2024 was ₹140.39Cr.
The net profit margin for Concord Biotech Ltd in the Q4 results 2024 was 31.96%.
The revenue for Concord Biotech Ltd in the Q4 results 2023 was ₹329.78Cr.
The net profit for Concord Biotech Ltd in the Q4 results 2023 was ₹95.02Cr.
The net profit margin for Concord Biotech Ltd in the Q4 results 2023 was 28.81%.